Low dose methotrexate is used increasingly often in the treatment of rheumatoid arthritis. Severe complications due to toxicity of the lung or bone marrow occur infrequently. This report describes a 71 year old woman with longstanding rheumatoid arthritis who developed pleuritis, a pulmonary infiltrate, and pancytopenia during treatment with low dose methotrexate. Fatal respiratory insufficiency followed, and cultures from the lung after death showed Nocardia asteroides.
Case report A 71 year old woman with a 34 year history of classical seropositive rheumatoid arthritis, who was previously unresponsive to gold, was maintained with naproxen (500 mg/day) and prednisone (10 mg/day). Because of a flare up of her arthritis methotrexate (7 5 mg/week) was started nine months before admission and naproxen was discontinued. Serial complete blood cell counts, hepatic enzyme test results, and renal function remained normal during that period. Further treatment consisted of paracetamol (1-2 g/day), digoxin (0-125 mg/day), frusemide (40 mg/day), triamterene (50 mg/day), famotidine (40 mg/day), and vitamin B. She was admitted to hospital because of progressive dyspnoea and chest pain. On admission she was afebrile with a pulse rate of 140/min and a blood pressure of 190 
